📅 2026 Update: Changes in Controlled Substance Prescribing

Since the original article was published, there have been important updates regarding the prescribing of controlled substances, particularly through telemedicine. These changes aim to improve access to treatments while maintaining safety measures. The earlier article continues further down the page to provide more context and details.

📱 Telemedicine Flexibilities Extended

The U.S. Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) have extended telemedicine flexibilities for prescribing controlled substances through December 31, 2026. This allows practitioners registered with the DEA to prescribe Schedule II-V medications via telehealth without needing a prior in-person visit.

This change is significant for patients looking for convenient access to care.

💊 Permanent Buprenorphine Telemedicine Rules

On January 17, 2025, a final rule was issued by the DEA and HHS that made telemedicine flexibilities for prescribing buprenorphine permanent. Buprenorphine is crucial for treating opioid use disorder, and this rule ensures that patients can continue accessing this treatment remotely.

🧠 Strengthened Mental Health Parity

New rules released on September 9, 2024, aim to strengthen the Mental Health Parity and Addiction Equity Act (MHPAEA). These rules enhance the equality of benefits between mental health, substance use disorder services, and medical benefits. The goal is to prevent insurance plans from imposing stricter limits on mental health services compared to other medical treatments.

⏰ Telehealth Prescription Processing Times

Processing times for telehealth prescriptions can vary based on the provider. Some platforms may offer same-day consultations, while others may take longer. Patients should be prepared for this variability when seeking prescriptions for controlled substances through telehealth.

📌 Key Points

  • Telemedicine flexibilities for controlled substances extended to December 31, 2026.
  • Permanent rules for buprenorphine prescribing via telemedicine.
  • Strengthened parity for mental health and addiction treatment benefits.
  • Processing times for telehealth prescriptions vary by provider.

💡 Tips for Navigating Telehealth Prescriptions

Reviewing your specific situation with your attorney can help clarify any legal concerns regarding your prescriptions and treatment options.

📋 Understand Eligibility Requirements

To receive telehealth prescriptions for controlled substances, ensure that the practitioner is registered with the DEA. A video consultation is necessary to assess your medical history and current condition.

💵 Check Costs for Telehealth Services

Costs for telehealth consultations can vary widely. It's important to check with individual providers about their pricing for visits related to controlled substances or buprenorphine treatment.

🕒 Plan for Variable Processing Times

Processing times for telehealth prescriptions can differ between platforms. Be aware that some providers may offer quicker access than others, impacting when you receive your medication.

📞 Utilize Free Resources

If you need assistance finding treatment for substance use disorders, consider reaching out to the Substance Abuse and Mental Health Services Administration (SAMHSA) helpline at 1-800-662-HELP (4357). They provide confidential support.

🔍 Stay Informed About Changes

Regulations regarding controlled substances can change. Stay updated on current laws and guidelines to ensure compliance and understand your rights as a patient.

🏆 Telehealth Services Ranked by User Reviews (2026)

This section lists telehealth services relevant to controlled substance prescriptions and mental health treatment. The rankings are based on Trustpilot data from October 2026, and while the star ratings reflect user experiences, it's important to remember that dissatisfied customers often leave more reviews, which can skew perceptions.

🥇 1. Hims & Hers Health

Hims & Hers Health has been rated 3.0. The service is known for its online healthcare services, including prescription medications and personal care products. However, it has faced issues related to customer service and product effectiveness, which some reviewers have noted.

🥈 2. LifeStance Health

LifeStance Health holds a rating of 4.0. It is recognized for its mental health services, offering therapy and psychiatry, along with telehealth options. Some users have reported inconsistent service quality and challenges with appointment availability.

🥉 3. Talkiatry

Talkiatry has a lower rating of 2.4. This service specializes in online psychiatry and medication management, providing flexible scheduling for patients. However, it has been critiqued for limited insurance coverage and variable clinician quality, which can affect patient satisfaction.

4️⃣ Direct Meds

Direct Meds boasts a score of 4.6. Known for its telehealth services focused on GLP-1 medications, it is recognized for quality verification in its offerings. Some users have mentioned limited insurance acceptance and potential side effects as points to consider.

🆓 Free Government and Nonprofit Help

The U.S. Department of Labor offers resources under the Mental Health Parity and Addiction Equity Act (MHPAEA). Patients can contact the Employee Benefits Security Administration for assistance, ensuring they understand their rights regarding mental health and addiction treatment benefits.

🔎 What to Compare When Choosing Telehealth Services

  • 📅 Availability of appointments
  • 💵 Cost of consultations
  • 🏥 Range of services offered
  • 📞 Customer service responsiveness

❓ Frequently Asked Questions

🧐 What are the eligibility requirements for telehealth prescriptions?

Patients must have a video consultation with a DEA-registered practitioner to receive telehealth prescriptions for controlled substances. The practitioner will evaluate the patient's medical history and current condition.

🕰️ How long does it take to get a telehealth prescription?

Processing times for telehealth prescriptions can vary by provider. Some may offer same-day consultations, while others might take several days for scheduling.

📞 Where can I find help for substance use disorders?

The Substance Abuse and Mental Health Services Administration (SAMHSA) offers a national helpline at 1-800-662-HELP (4357) for those seeking information and treatment referrals for mental health and substance use disorders.

💸 Are there costs associated with telehealth consultations?

Yes, costs for telehealth consultations can vary widely depending on the provider. Some may have subscription models, while others charge per visit.

🧠 What does mental health parity mean?

Mental health parity refers to the requirement that health plans provide equal benefits for mental health and substance use disorder services compared to medical and surgical benefits. New rules aim to strengthen this parity.

📚 How can I find current information on drug regulations?

To stay informed about changes in drug classifications and regulations, regularly review updates from reputable sources or consult healthcare professionals for the latest information.

⚖️ Recent Cases Related to Controlled Substances

Recent court rulings have focused on the legal aspects of prescribing controlled substances, impacting both providers and patients. These cases often highlight the balance between access to necessary medications and the need for safety regulations.

For more recent rulings, feel free to check more rulings on the news page.

End of October 2026 Update





What is Neurontin?



Neurontin, generically known as Gabapentin, is a pharmaceutical drug developed by Pfizer that was approved by the FDA in 2004 for the treatment of a number of neurological conditions, notably epilepsy, neuropathic pain and seizures.  The drug is used for pain relief and has been found to be beneficial in one-third of patients.  This includes neuropathy and some forms of cancer.  In neuropathic disorders Neurontin works by stabilizing misfiring nerves by slowing down neurological impulses traveling from the spinal cord to peripheral tissues.  The reason why Neurontin works in epilepsy patients is unknown as of this moment.

Neurontin

Side Effects



The most common side effects associated with Neurontin are dizziness, drowsiness, and peripheral edema.  The drug has also been associated with increased risks of suicide and/or violent deaths. 

Government Regulations



In 2009 the FDA, after concluding a study, issued warnings to physicians and patients notifying them of an increased risk of depression and suicidal tendencies in patients who have taken Neurontin and other drugs of its nature.  Currently there is debate in Congress over the ability of Pharmaceutical manufacturers to promote "off-label" uses for drugs.  As the Neurontin example shows, this can lead to abuse of the system and essentially make FDA decisions void.

Lawsuits



Neurontin has been the subject of much litigation over Pfizer's treatment of the drug.  In 2004 a subsidiary of Pfizer pleaded guilty to promoting Neurontin for unapproved uses and ultimately paid $430 million combined for criminal fines as well as civil liabilities and personal injuries.  In 2009 Pfizer settled a wrongful death action based on a suicide blamed on Neurontin use.  The complaint alleged that Pfizer intentionally and deceptively altered scientific reports to promote the drug for specific uses.

There have been continuous allegations that Pfizer promoted the drug for "off-label" use that is use by a physician above that recommended by the FDA.  The promotion and marketing of the drug for off-label use has been considered fraud by many and in 2010 a United States District Court in Massachusetts found in favor of defendant, Kaiser Foundation, for $47 million for violation of RICO laws.  The plaintiff alleged that Pfizer misled the Kaiser Foundation into believing that migraines and bi-polar disorder could be treated effectively with Neurontin.  This was done despite the fact that there was no label on the product indicating its effectiveness, or even, approval for these conditions.  Because this is a RICO law the award was permitted to be trebled and Pfizer stands to pay $142 million in damages. 

What to do if treated for "off-label" use of Neurontin

If you or someone you know has been prescribed Neurontin for any use not designated by the label or you have developed suicidal tendencies or other adverse effects from the use of the product it is essential that you seek a physician's expertise.  Upon treatment you should consult an attorney specializing in either personal injury or class action suits involving pharmaceutical products, especially those knowledgeable about Neurontin.